tiprankstipranks
Telesis Bio (TBIO)
NASDAQ:TBIO
US Market

Telesis Bio (TBIO) Financial Statements

111 Followers

Telesis Bio Financial Overview

Telesis Bio's market cap is currently ―. The company's EPS TTM is $-28.308; its P/E ratio is -0.13; Telesis Bio is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-4.03. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 3.44M$ 5.56M$ 8.65M$ 6.32M$ 9.47M
Gross Profit$ 1.45M$ 3.00M$ 5.69M$ 3.51M$ 6.45M
EBIT$ -8.42M$ -9.93M$ -8.28M$ -10.87M$ -7.88M
EBITDA$ -7.22M$ -9.08M-$ -9.64M$ -6.94M
Net Income Common Stockholders$ -9.22M$ -11.20M$ -8.44M$ -11.12M$ 5.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.60M$ 41.45M$ 47.35M$ 23.53M$ 30.59M
Total Assets$ 63.33M$ 105.03M$ 114.53M$ 89.16M$ 81.36M
Total Debt$ 36.12M$ 49.92M$ 49.26M$ 50.43M$ 34.59M
Net Debt$ 20.52M$ 8.46M$ 1.91M$ 26.89M$ 3.99M
Total Liabilities$ 41.68M$ 58.54M$ 58.46M$ 52.54M$ 34.80M
Stockholders Equity$ -8.24M$ 17.77M$ 27.92M$ 36.62M$ 46.56M
Cash Flow-
Free Cash Flow$ -3.74M$ -5.98M-$ -11.65M$ -6.40M
Operating Cash Flow$ -3.24M$ -5.89M$ -10.30M$ -11.18M$ -5.64M
Investing Cash Flow$ 12.25M$ -23.21M$ 6.85M$ 4.12M$ 11.21M
Financing Cash Flow$ -27.00K$ -101.00K$ 26.70M$ -20.00K$ 108.00K
Currency in USD

Telesis Bio Earnings and Revenue History

Telesis Bio Debt to Assets

Telesis Bio Cash Flow

Telesis Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis